Source document or public record

FDA 510(k) K241915 — CareSuperb™ COVID-19 Antigen Home Test

FDA 510(k) index record K241915. Device: CareSuperb™ COVID-19 Antigen Home Test. Applicant as listed: Access Bio, Inc.. Decision date: 2025-01-29.

OtherU.S. Food and Drug Administration (FDA)2025-01-29

Source

"device_name": "CareSuperb™ COVID-19 Antigen Home Test"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K241915.

Device name: CareSuperb™ COVID-19 Antigen Home Test. Applicant as listed: Access Bio, Inc..

Decision date: 2025-01-29. Decision wording: Substantially Equivalent.

Product code: QYT. Regulation: 21 CFR 866.3984. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.